Biologik ApS: Financial statements 2017
CVR: 36070498
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
Biologik ApS (CVR 36070498) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 141,508 and a net result of DKK 46,654 compared with DKK -93,611 the year before. That is an increase of 11.4% compared with the year before. Equity in the 2017 report amounted to DKK -66,955. The company had 1 employee in the financial year.
- Gross Profit
- DKK 141,508
- Profit/Loss
- DKK 46,654
- Equity
- DKK -66,955
- Total Assets
- DKK 98,958
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 142K | 47K | -67K | 1 |
| 2016 | - | 127K | -94K | -114K | - |
| 2015 | - | 110K | -70K | -20K | - |
Official annual report
Keep an eye on Biologik ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Biologik ApS
Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named EPOQE ApS. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee (2024). In 2026, the company reported a gross profit of DKK 1,028,840 and a net result of DKK 805,458 compared with DKK 234,499 the year before. Equity in the 2026 report amounted to DKK 1,150,734.